IM Cannabis Corp
NASDAQ:IMCC
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.9985
6.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
I
|
IM Cannabis Corp
CNSX:IMCC
|
9.7m CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
525.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
277B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210.3B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.9B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
271.6B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
148.4B USD |
Loading...
|
Market Distribution
| Min | -9 940 586.9% |
| 30th Percentile | -85.9% |
| Median | -7.8% |
| 70th Percentile | 5.5% |
| Max | 60 777.6% |
Other Profitability Ratios
IM Cannabis Corp
Glance View
IM Cannabis Corp. engages in the production and sale of medical cannabis products. The company is headquartered in Vancouver, British Columbia and currently employs 283 full-time employees. The firm operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), where it cultivates, imports and distributes cannabis to medical patients, data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers and logistical hubs in Israel. The firm operates in Germany through Adjupharm GmbH (Adjupharm), where it is a certified medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses. The firm operates in Canada through Trichome JWC Acquisition Corp. d/b/a JWC and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for IM Cannabis Corp is -8.6%, which is above its 3-year median of -114%.
Over the last 3 years, IM Cannabis Corp’s Net Margin has increased from -34.9% to -8.6%. During this period, it reached a low of -347.6% on Dec 31, 2022 and a high of -8.6% on Apr 3, 2025.